, /PRNewswire/ -- Petauri, a leading purpose-built pharmaceutical services platform, announced today the addition of two UK-based firms: Mtech Access, a premier full-service global market access solutions provider; and Delta Hat, an experience-led company specializing in the technical aspects of evidence-based value demonstration. The combined business will create a comprehensive suite of highly technical and specialized services that will deliver unparalleled value to Petauri clients globally. Today's announcement marks a pivotal moment in Petauri's growth trajectory as the platform now numbers more than 300 global professionals, all dedicated to the vision of improving patient outcomes by speeding access to life-changing medical advances.
"The integration of Mtech Access and Delta Hat allows us to support clients with more robust and comprehensive capabilities in the critical areas of global market access, evidence generation, and technical specialization delivered by world-renowned scientists and researchers," said , CEO of Petauri. "We are confident that this expansion of core capabilities will accelerate our mission to ensure that scientific breakthroughs reach patients with unmet medical needs." "Joining Petauri alongside Delta Hat is a proud moment for me and my co-founders, and ," said , Founder and Managing Director, Mtech Access.
"When we started the company 8 years ago, I was committed to building a 'people first' business focused on delivering the best possible ou.
